Heme Oxygenase-1 is Required for Angiogenic Function of Bone Marrow-derived Progenitor Cells: Role in Therapeutic Revascularization
Overview
Authors
Affiliations
Aims: Heme oxygenase-1 (HO-1) is a cytoprotective enzyme that can be down-regulated in diabetes. Its importance for mature endothelium has been described, but its role in proangiogenic progenitors is not well known. We investigated the effect of HO-1 on the angiogenic potential of bone marrow-derived cells (BMDCs) and on blood flow recovery in ischemic muscle of diabetic mice.
Results: Lack of HO-1 decreased the number of endothelial progenitor cells (Lin(-)CD45(-)cKit(-)Sca-1(+)VEGFR-2(+)) in murine bone marrow, and inhibited the angiogenic potential of cultured BMDCs, affecting their survival under oxidative stress, proliferation, migration, formation of capillaries, and paracrine proangiogenic potential. Transcriptome analysis of HO-1(-/-) BMDCs revealed the attenuated up-regulation of proangiogenic genes in response to hypoxia. Heterozygous HO-1(+/-) diabetic mice subjected to hind limb ischemia exhibited reduced local expression of vascular endothelial growth factor (VEGF), placental growth factor (PlGF), stromal cell-derived factor 1 (SDF-1), VEGFR-1, VEGFR-2, and CXCR-4. This was accompanied by impaired revascularization of ischemic muscle, despite a strong mobilization of bone marrow-derived proangiogenic progenitors (Sca-1(+)CXCR-4(+)) into peripheral blood. Blood flow recovery could be rescued by local injections of conditioned media harvested from BMDCs, but not by an injection of cultured BMDCs.
Innovation: This is the first report showing that HO-1 haploinsufficiency impairs tissue revascularization in diabetes and that proangiogenic in situ response, not progenitor cell mobilization, is important for blood flow recovery.
Conclusions: HO-1 is necessary for a proper proangiogenic function of BMDCs. A low level of HO-1 in hyperglycemic mice decreases restoration of perfusion in ischemic muscle, which can be rescued by a local injection of conditioned media from cultured BMDCs.
Gasotransmitter-Induced Therapeutic Angiogenesis: A Biomaterial Prospective.
Robert B, Subramaniam S ACS Omega. 2022; 7(50):45849-45866.
PMID: 36570231 PMC: 9773187. DOI: 10.1021/acsomega.2c05599.
Myeloid cell-specific ablation of Runx2 gene exacerbates post-infarct cardiac remodeling.
Tomimatsu M, Matsumoto K, Ashizuka M, Kumagai S, Tanaka S, Nakae T Sci Rep. 2022; 12(1):16656.
PMID: 36198906 PMC: 9534857. DOI: 10.1038/s41598-022-21202-7.
Wang K, Sun S, Zhang G, Lu Z, Chen H, Fan X Cardiovasc Drugs Ther. 2022; 37(5):849-863.
PMID: 35471717 PMC: 10926281. DOI: 10.1007/s10557-022-07337-9.
Rodriguez-Gonzalez J, Hernandez-Balmaseda I, Declerck K, Perez-Novo C, Logie E, Theys C Front Pharmacol. 2021; 12:670167.
PMID: 34924998 PMC: 8678272. DOI: 10.3389/fphar.2021.670167.
Fluid shear stress regulates placental growth factor expression via heme oxygenase 1 and iron.
Rashdan N, Zhai B, Lovern P Sci Rep. 2021; 11(1):14912.
PMID: 34290391 PMC: 8295300. DOI: 10.1038/s41598-021-94559-w.